Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Verve Therapeutics Inc (NASDAQ: VERV) was $5.77 for the day, down -2.20% from the previous closing price of $5.90. In other words, the price has decreased by -$2.20 from its previous closing price. On the day, 0.53 million shares were traded. VERV stock price reached its highest trading level at $5.97 during the session, while it also had its lowest trading level at $5.63.
Ratios:
Our analysis of VERV’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 13.05 and its Current Ratio is at 13.05. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on April 08, 2024, initiated with a Buy rating and assigned the stock a target price of $15.
On April 13, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $29.
On February 01, 2023, Cantor Fitzgerald started tracking the stock assigning a Neutral rating and target price of $21.Cantor Fitzgerald initiated its Neutral rating on February 01, 2023, with a $21 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 02 ’24 when Dorval Allison sold 555 shares for $5.64 per share. The transaction valued at 3,130 led to the insider holds 5,380 shares of the business.
Ashe Andrew D. bought 76,000 shares of VERV for $475,760 on May 14 ’24. The insider now owns 342,509 shares after completing the transaction at $6.26 per share. On Apr 02 ’24, another insider, Nickerson Joan, who serves as the Chief Administrative Officer of the company, sold 1,514 shares for $8.24 each. As a result, the insider received 12,475 and left with 8,659 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERV now has a Market Capitalization of 488510112 and an Enterprise Value of 17305442. For the stock, the TTM Price-to-Sale (P/S) ratio is 19.58 while its Price-to-Book (P/B) ratio in mrq is 0.96. Its current Enterprise Value per Revenue stands at 0.709 whereas that against EBITDA is -0.079.
Stock Price History:
Over the past 52 weeks, VERV has reached a high of $19.34, while it has fallen to a 52-week low of $4.30. The 50-Day Moving Average of the stock is -0.53%, while the 200-Day Moving Average is calculated to be -9.79%.
Shares Statistics:
VERV traded an average of 1.46M shares per day over the past three months and 1675710 shares per day over the past ten days. A total of 84.64M shares are outstanding, with a floating share count of 63.10M. Insiders hold about 25.47% of the company’s shares, while institutions hold 76.15% stake in the company. Shares short for VERV as of 1732838400 were 17872710 with a Short Ratio of 10.91, compared to 1730332800 on 17228638. Therefore, it implies a Short% of Shares Outstanding of 17872710 and a Short% of Float of 25.2.
